PATENT CLAIM ANALYSIS

Application Number: 15927459
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006100"]

Abstract:
Disclosed herein is a marker composition that includes sphingosine 1-phosphate (S1P) lipid and that may be used to predict the risk of fracture or osteoporosis; a kit that includes an antibody that specifically binds to the S1P lipid and that can be used to predict the risk of fracture or osteoporosis; and a method that can be used to obtain information that allows prediction of the risk of fracture or osteoporosis and includes measurements of S1P lipid concentrations by measuring the binding of a S1P-specific antibody to SIP lipid. The S1P lipid disclosed herein is highly expressed in individuals with fracture, regardless of their bone mineral density. Accordingly, it may be useful as a biomarker of the risk of fracture or osteoporosis.

Claim (Index 1):
A kit for predicting the risk of fracture or osteoporosis comprising:\n a sphingosine 1-phosphate (S1P) lipid-specific antibody; and an agent to measure the amount of S1P lipid-specific antibody that bind to S1P lipid.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 2.04688
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13173701', '10428367', '14094040', '11228126', '10809578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5843713468643355
- 35 USC 102 Novelty (BERT): 0.4931236875926791
- Combined Prediction Score: 0.5752465809371698
- Mean Citation Score: 180.990116
- Max Citation Score: 190.65912
- Similarity Product: 118.76290856549264

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test